CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-05-14

Key Insights

Director Nancy C. Andrews transferred 3,964 shares to a revocable trust she controls on 05/12/2026, representing an exempt transfer under Rule 16a-13 with no change in beneficial ownership.
The transaction shows Andrews maintaining her direct beneficial ownership of 1,438 shares while adding 3,964 shares indirectly through the trust, indicating estate planning or asset protection structuring rather than a market-driven buy or sell decision.
This trust transfer is a routine administrative action for an insider director and does not signal confidence or concern about the company's future prospects or stock valuation.

Want the newest filings?

This analysis covers the filing from 2026-05-14. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-05-12

Director Paul Graves acquired 1,438 shares of CRL common stock on 05/08/2026 at $177.62 per share, increasing his direct beneficial ownership to 2,384 shares, demonstrating insider confidence in the company's valuation.
The acquired shares consist of unvested restricted stock units (RSUs) that vest on the earlier of May 8, 2027 or the business day prior to the next annual shareholder meeting, indicating this is equity compensation rather than open market purchase.
As a director with this acquisition, Graves maintains a modest shareholding position relative to typical institutional investor stakes, suggesting this is standard director compensation rather than a significant conviction buy or sell signal.

Filed: 2026-05-12

Director Craig B. Thompson acquired 1,438 shares of common stock at $177.62 per share on 05/08/2026, bringing his total beneficial ownership to 3,851 shares, suggesting confidence in the company's valuation at this price level.
The acquisition consists of unvested restricted stock units that vest on the earlier of 05/08/2027 or the business day prior to the next annual shareholder meeting, indicating this is a compensation-related grant rather than open market purchase.
Thompson's filing shows a relatively modest shareholding position despite his director status, with total beneficial ownership of only 3,851 shares, which may indicate limited personal capital commitment compared to institutional investors.

Filed: 2026-05-12

Director Steven Barg acquired 1,438 shares of CRL common stock at $177.62 per share on 05/08/2026, increasing his direct beneficial ownership to 2,865 shares, indicating insider confidence in the company's valuation.
The acquisition consists of unvested restricted stock units that vest on the earlier of 05/08/2027 or the business day prior to the next annual shareholder meeting, representing a typical equity compensation arrangement for board members.
This is a routine insider transaction by a director with no material trading pattern concerns; the modest share count and vesting schedule suggest standard director compensation rather than a significant strategic position change.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.